Amidolytic and peptidolytic activities of immunoglobulin G present in sera from patients with rheumatoid arthritis, Sjogren's syndrome and systemic lupus erythematosus

Immunology

Volumn 95, Issue 1, 1998, Pages 26-30

  Matsuura, K ^a   Ikoma, S ^a   Sugiyama, M ^a   Funauchi, M ^a   Sinohara, H ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; ANILIDE; BENZYLOXYCARBONYLVALYLGLYCYLARGININE 4 NITROANILIDE; DEXTRO PROLYLPHENYLALANYLARGININE 4 NITROANILIDE; DEXTRO PROLYLPHENYLALANYLARGININE METHYLCOUMARINAMIDE; GLUTAMINYLARGINYLARGINYLALANYLALANINE; IMMUNOGLOBULIN G; PENTAPEPTIDE; PEPTIDE; PLASMA KALLIKREIN; POLYCLONAL ANTIBODY; TRYPSIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYDROLYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RHEUMATOID ARTHRITIS; SERUM; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AMIDES; ANILINE COMPOUNDS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMOGENIC COMPOUNDS; EPITOPES; HLA-DR ANTIGENS; HUMANS; HYDROLYSIS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; SJOGREN'S SYNDROME; STATISTICS, NONPARAMETRIC;

EID: 0031710039     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00572.x     Document Type: Article

References (23)

1. POWERS J.C. & HARPER J.W. (1986) Inhibitors of serine proteinases. In: Proteinase Inhibitors (eds A. J. Barrett & G. Salvesen) p. 55. Elsevier, Amsterdam.
2. ERHAN S. & GRELLER L.D. (1974) Do immunoglobulins have proteolytic activity? Nature 251, 353.
3. PAUL S. (1996) Natural catalytic antibodies. Mol Biotechnol 5, 197.
4. PAUL S., SUN M., MODY R. et al. (1991) Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies. J Biol Chem 266, 16128.
5. L fragment. J Biol Chem 270, 15257.
6. LI L., PAUL S., TYUTYUKOVA S., KAZATCHKINE M. & KZVERI S. (1995) Catalytic activity of anti-thyroglobulin antibodies. J Immunol 154, 3328.
7. MEI S., MODY B., EKLUND S.H. & PAUL S. (1991) Vasoactive intestinal peptide hydrolysis by antibody light chains. J Biol Chem 266, 15571.
8. MATSUURA K., YAMAMOTO K. & SINOHARA H. (1994) Amidase activity of human Bence Jones proteins. Biochem Biophys Res Commun 204, 57.
9. MATSUURA K. & SINOHARA H. (1996) Catalytic cleavage of vasopressin by human Bence Jones proteins at the arginylglycinamide bond. Biol Chem 377, 587.
10. KABAT E.A., WU T.T., PERRY H.M., GOTTESMAN K.S. & FOELLER C. (1991) Sequences of Proteins of Immunological Interest. Vol 1, 5th edn. Public Health Service National Institutes of Health, NIH Publication No. 91-3242, Bethesda, MD.
11. KALAGA R., LI L., O'DELL J.R. & PAUL S. (1995) Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J Immunol 155, 2695.
12. GREGERSEN P.K., SILVER J. & WINCHWSTER R.J. (1987) The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30, 1205.
13. ARNETT F.C., EDWORTHY S.M., BLOCH D.A. et al. (1988) The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 31, 315.
14. TAN E.M., COHEN A.S., FRIES J.F. et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25, 1271.
15. VITALI C., BOMBARDIERI S., MOUTSOPOULOS H.M. et al. (1993) Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36, 340.
16. MERRIFIELD B. (1986) Solid phase synthesis. Science 232, 341.
17. NOKIHARA K., NAGAWA Y., HONG S.-P. & NAKANISHI H. (1997) Efficient solid-phase synthesis of a large peptide by a single coupling protocol with a single HPLC purification step. Lett Peptide Sci 4, 141.
18. YAMAMOTO T., YAMAMOTO K. & SINOHARA H. (1996) Inter-α-trypsin inhibitor and its related proteins in Syrian hamster urine and plasma. J Biochem 120, 145.
19. SCHECHTER I. & BERGER A. (1967) On the size of the active site in proteases. I. Papain. Biochem Biophys Rex Commun 27, 157.
20. NEPOM G.T., BYERS P., SEYFRIED C. et al. (1989) HLA genes associated with rheumatoid arthritis: identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 32, 15.
21. TAKEUCHI F., MATSUTA K., WATANABE Y., TOKUNAGA K., JUJI T. & MIYAMOTO T. (1990) Susceptibility epitope on HLA-DRβ chain for rheumatoid arthritis and the effect of the positivity on the clinical features. J Immunogenetics 16, 475.
22. WOULFE S.L., BONO C.P., ZACHEIS M.L. et al. (1995) Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401. Arthritis Rheum 38, 1744.
23. HONG G.H., PARK M.H., TAKEUCHI F. et al. (1996) Association of specific amino acid sequence of HLA-DR with rheumatoid arthritis in Koreans and its diagnostic value. J Rheumatol 23, 1699.